Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Atopic dermatitis | D003876 | EFO_0000274 | L20 | 2 | 4 | 8 | — | — | 14 |
Dermatitis | D003872 | — | L30.9 | 2 | 4 | 8 | — | — | 14 |
Eczema | D004485 | — | L30.9 | 1 | 4 | 8 | — | — | 13 |
Drug common name | Difamilast |
INN | difamilast |
Description | Difamilast is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target 3',5'-cyclic-AMP phosphodiesterase 4D; cAMP-specific 3',5'-cyclic phosphodiesterase 4D. |
Classification | Small molecule |
Drug class | antiasthmatics/antiallergics (not acting primarily as antihistamines): type IV phosphodiesterase |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCOc1ccccc1C(=O)NCc1coc(-c2ccc(OC(F)F)c(OC(C)C)c2)n1 |
PDB | — |
CAS-ID | 937782-05-3 |
RxCUI | — |
ChEMBL ID | CHEMBL3989968 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | T3U32GLJ0F (ChemIDplus, GSRS) |